Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Spada

Showing results (101-110 of 120) with videos related to

Pageof 12
Sort By:
Annals of Surgery|July 12, 2018
Morphological Factors Related to Nodal Metastases in Neuroendocrine Tumors of the Appendix: A Multicentric Retrospective StudyNicole Brighi, Stefano La Rosa, Giulio Rossi, et al.
Therapeutic Advances in Medical Oncology|June 17, 2024
Circulating tumor DNA in patients with locally advanced rectal cancer treated with multimodal treatmentLorenzo Gervaso, Davide Ciardiello, Giuliana Gregato, et al.
The Lancet Regional Health. Europe|April 22, 2026
Real-world presentation and outcomes of gastroenteropancreatic neuroendocrine neoplasms in Italy: findings from the nationwide Itanet prospective databaseFrancesco Panzuto, Maria Rinzivillo, Stefano Partelli, et al.
The New England Journal of Medicine|October 22, 2025
Belzutifan for Advanced Pheochromocytoma or ParagangliomaCamilo Jimenez, Mikkel Andreassen, Alice Durand, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|January 24, 2018
Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: A real-world studyMaria Rinzivillo, Nicola Fazio, Sara Pusceddu, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 10, 2026
Task-oriented virtual reality and brain functional plasticity in progressive multiple sclerosis: A randomized controlled trial on upper limb rehabilitationMehrnaz Hamedani, Giada Lombardi, Giacomo Boffa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2021
Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509)Jaume Capdevila, Nicola Fazio, Carlos Lopez, et al.
Cancer Medicine|May 27, 2017
Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumorsRossana Berardi, Mariangela Torniai, Sara Pusceddu, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2024
A randomized phase II trial of Captem or Folfiri as second-line therapy in neuroendocrine carcinomasAlberto Bongiovanni, Chiara Liverani, Flavia Foca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2026
Axitinib and Long-Acting Octreotide in Advanced Extrapancreatic Neuroendocrine Tumors: A Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trial (AXINET, GETNE 1107)Rocio Garcia-Carbonero, Marta Benavent, Paula Jimenez-Fonseca, et al.
Pageof 12

Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
Annals of Surgery|July 12, 2018
Morphological Factors Related to Nodal Metastases in Neuroendocrine Tumors of the Appendix: A Multicentric Retrospective StudyNicole Brighi, Stefano La Rosa, Giulio Rossi, et al.
Therapeutic Advances in Medical Oncology|June 17, 2024
Circulating tumor DNA in patients with locally advanced rectal cancer treated with multimodal treatmentLorenzo Gervaso, Davide Ciardiello, Giuliana Gregato, et al.
The Lancet Regional Health. Europe|April 22, 2026
Real-world presentation and outcomes of gastroenteropancreatic neuroendocrine neoplasms in Italy: findings from the nationwide Itanet prospective databaseFrancesco Panzuto, Maria Rinzivillo, Stefano Partelli, et al.
The New England Journal of Medicine|October 22, 2025
Belzutifan for Advanced Pheochromocytoma or ParagangliomaCamilo Jimenez, Mikkel Andreassen, Alice Durand, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|January 24, 2018
Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: A real-world studyMaria Rinzivillo, Nicola Fazio, Sara Pusceddu, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 10, 2026
Task-oriented virtual reality and brain functional plasticity in progressive multiple sclerosis: A randomized controlled trial on upper limb rehabilitationMehrnaz Hamedani, Giada Lombardi, Giacomo Boffa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2021
Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509)Jaume Capdevila, Nicola Fazio, Carlos Lopez, et al.
Cancer Medicine|May 27, 2017
Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumorsRossana Berardi, Mariangela Torniai, Sara Pusceddu, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2024
A randomized phase II trial of Captem or Folfiri as second-line therapy in neuroendocrine carcinomasAlberto Bongiovanni, Chiara Liverani, Flavia Foca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2026
Axitinib and Long-Acting Octreotide in Advanced Extrapancreatic Neuroendocrine Tumors: A Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trial (AXINET, GETNE 1107)Rocio Garcia-Carbonero, Marta Benavent, Paula Jimenez-Fonseca, et al.
Pageof 12